UPCOMING SESSIONS in ET
Wed, Apr 22, 2026
10:00 – 11:00 PM UTC
Cardiac transplantation in amyloidosis - who, when, and (then) what Hasan Siddiqi MD, MSCR Click To Register
UPCOMING SESSIONS in ET
Wed, Apr 22, 2026 · 10:00 – 11:00 PM UTC
Cardiac transplantation in amyloidosis - who, when, and (then) what
Hasan Siddiqi MD, MSCR
Click To Register
View all sessions

News

Transthyretin Cardiac Amyloidosis
Mar 28, 2026
Transthyretin Cardiac Amyloidosis
 I would like to attend…Live In Person in New OrleansSaturday, March 28, 20266:30-7:00 AM CDT: Registration & Breakfast7:00-8:00 AM CDT: SymposiumVirtually…
Read more
amyloidosis
Mar 27, 2026
Immutrin bags $87m for heart amyloid therapy
Fresh funding backs a high-stakes attempt to do what current amyloidosis drugs still cannot: clear the buildup already damaging the heart.UK-based biotech Immutrin…
Read more
amyloidosis
Mar 26, 2026
Amyloidosis
Amyloidosis is a rare disease involving the formation and spread of abnormal proteins in the body. Unlike with other proteins, the body cannot naturally recycle…
Read more
amyloidosis
Mar 26, 2026
Head-to-head comparison of 11C-PiB and 18F-flutemetamol PET in transthyretin cardiac amyloidosis
PurposeAmyloid positron emission tomography (PET) tracers are increasingly used to detect cardiac amyloidosis (CA). 11C-Pittsburgh compound B (PiB) and 1⁸F-…
Read more
amyloidosis
Mar 25, 2026
Viz.ai and Alnylam Partner to Advance AI-Driven Detection and Care Coordination in Cardiac Amyloidosis
Viz.ai has announced a partnership with Alnylam Pharmaceuticals to improve early identification and care coordination for patients with cardiac amyloidosis, a…
Read more
Amyloid Education Series 2.0, Part 3: Cases and Clinical Conundrums in Amyloidosis Management
Mar 25, 2026
Amyloid Education Series 2.0, Part 3: Cases and Clinical Conundrums in Amyloidosis Management
Join the CCS for the third and final installment of the Amyloid Education Series 2.0 in the upcoming webinar, ‘Cases and Clinical Conundrums in Amyloidosis…
Read more
Subscribe to